169321 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids Cytokines, i.e. immune system proteins modifying a biological response such as cell growth proliferation or differentiation, e.g. TNF, CNF, GM-CSF, lymphotoxin, MIF or their receptors
Methods for producing ex vivo models for inflammatory disease and uses thereof
#1202METHODS, PHARMACEUTICAL FORMULATIONS AND KITS FOR IDENTIFICATION OF SUBJECTS AT RISK FOR CANCER
#1203Assessment and reduction of risk of graft-versus-host disease
#1204Systems and methods for characterizing kidney diseases
#1205Histamine detection method and histamine detection kit
#1206Method for screening substances capable of promoting oligomerization of receptor protein molecules
#1207Rapid Determination of Hepatocyte Growth Factor (Hgf) in the Body Fluids
#1208Methods of reducing skin damage and edema
#1209Methods and compositions related to B cell assays
#1210ELISA for VEGF
#1211Domain antibody construct
#1212Systems and methods for monitoring immune responses and predicting outcomes in transplant recipients
#1213Cell migration assay
#1214Monocyte activation test better able to detect non-endotoxin pyrogenic contaminants in medical products
#1215Method of diagnosing diseases relating to endometriosis
#1216Novel Cytokine Receptors and Nucleic Acids Encoding the Same
#1217Detecting and predicting pre-eclampsia
#1218IL-1 zeta splice variant polypeptide
#1219Constitutively active CXCR3 G protein-coupled chemokine receptor and modulators thereof for the treatment of inflammatory disorders
#1220Methods and compounds for disruption of CD40R/CD40L signaling in the treatment of Alzheimer's disease
#1221Methods of modulating cell surface receptors to prevent or reduce inflammation
#1222Receptor coupling agents and compositions thereof
#1223Methods for assessing the pro-inflammatory immune health of an individual
#1224Methods for recommending a program to improve or maintain pro-inflammatory immune health
#1225A METHOD FOR ASSESSING THE EFFICACY OF A PROGRAM TO IMPROVE OR MAITAIN THE PRO-INFLAMMATORY IMMUNE HEALTH
#1226Assays and methods using biomarkers
#1227Systems and methods for characterizing conditions and diseases associated with organ transplantation and organ health
#1228METHODS AND COMPOSITIONS FOR MODULATING HGF/MET
#1229Genobix agonists and antagonists for use in the treatment of metabolic disorders
#1230Method for predicting the developmetn of allergic disease
#1231Diagnostic application of mail
#1232Methods of treating idiopathic pulmonary fibrosis
#1233VEGF-C or VEGF-D materials and methods for treatment of neuropathologies
#1234Chemokine PANEC-2 polypeptides and compositions and methods related thereto
#1235Compositions and methods for IL-13 biomarkers
#1236Method for identifying type-1 interferon responsive ms patients by determining trail expression
#1237Human cytokine and alpha-helix-containing polypeptides
#1238Nucleic acid encoding eosinophil eotaxin receptor
#1239Diagnostic markers of wound infection III
#1240Cytokine receptor modulators and method of modulating cytokine receptor activity
#1241Method for detection of MIP-4 and CCRL2 binding and activity modulating agents
#1242Method of determining cytokine dosage for improving myelosuppressive state
#1243Methods and compositions for diagnosing and monitoring transplant rejection
#1244Interleukin-8 homologous polypeptides and therapeutic uses thereof
#1245Trimeric binding proteins for trimeric cytokines
#1246Biomarkers of resistance to infections in humans and biological applications thereof
#1247Human tumor necrosis factor TR21 and methods based thereon
#1248Method of screening for inhibitors of osteopontin
#1249Anti-neurturin receptor-A antibody compositions comprising cytokines or neurotrophic factors
#1250Artery-and vein-specific proteins and uses therefor
#1251Lymphoid chemokines in the diagnosis, monitoring and treatment of inflammatory disease
#1252WSX receptor agonist antibodies
#1253Methods of using IL-21 for adoptive immunotherapy and identification of tumor antigens
#1254Methods of high-throughput screening for internalizing antibodies
#1255Methods and compositions for beryllium-induced Disease
#1256Molecular dissection of cellular responses to alloantigen or autoantigen in graft rejection and autoimmune disease
#1257Compositions and methods of treating HIV infections
#1258Short peptides from the ‘2loop’ of 7 transmembrane receptor which selectively modulate signal transduction
#1259Method of screening for therapeutics for infectious diseases
#1260Antibodies that bind CCX-CKR2
#1261Methods of identifying cellular target molecules
#1262Detection of an immune response to GDF-8 modulating agents
#1263Method of evaluating a subject for risk or predisposition of reduced renal function over time
#1264Antibodies to myeloid progenitor inhibitory factor-1 (MPIF-1)
#1265Immunologic activity measures for t helper on-associated conditions
#1266Test kit
#1267Interleukin-8 homologous polypeptides and therapeutic uses thereof
#1268Prevention and treatment of amyloid-associated disorders
#1269Copper-dependent non-traditional pro-inflammatory cytokine export and methods, compositions and kits relating thereto
#1270TNF receptor action modulation
#1271Novel composition and methods for the treatment of immune disorders
#1272Diagnostic test
#1273Methods of treatment using antibodies to Neutrokine-alpha
#1274Chemokine-binding protein and methods of use
#1275Heteroduplex tracking assay
#1276Compositions and methods for diagnosing and treating prostate cancer
#1277Methods of Treatment Using Antibodies to Neutrokine-alpha
#1278Method of determining cytokine dosage for myelosuppressive state
#1279Screening methods
#1280Methods and products for enhancing immune responses using imidazoquinoline compounds
#1281Osteogenesis-promotion enhancer and method of screening the same
#1282Method for screening substances capable of promoting oligomerization of receptor protein molecules
#1283Eotaxin: eosinophil chemotactic cytokine
#1284Methods and kits for detecting heparin/platelet factor 4 antibodies
#1285Potent, selective and non toxic c-kit inhibitors
#1286Method of potentiating inflammatory and immune modulation for cell and drug therapy
#1287Method for identifying and designing immunogenic peptides
#1288Assays for fprl-1 ligands
#1289Cytokine designated 4-1BB ligand and human receptor that binds thereto
#1290Materials and methods for treating cancer
#1291Receptor and screening methods
#1292Sphingosine kinase-1 mediates gene expression regulation of a monocyte chemoattractant protein-1 gene
#1293Relevance of achieved levels of markers of systemic inflammation following treatment
#1294Gene expression profiling for identification monitoring and treatment of multiple sclerosis
#1295Therapeutic use of farnesyltransferase inhibitors and methods of monitoring the efficacy thereof
#1296Cytokine designated 4-1BB ligand and human receptor that binds thereto
#1297Mammalian cytokines; receptors; related reagents and methods
#1298Method of using cytokine assays to diagnose treat, and evaluate inflammatory and autoimmune diseases
#1299Method of treatment and prophylaxis
#1300Method of evaluating myelosuppressive state
#1301Methods and compositions for diagnosing and monitoring transplant rejection
#1302Duffy antigen receptor for chemokines and use thereof
#1303Methods for the prevention against or treatment of diabetes with ETXB and/or insulin
#1304Antibodies for IL-17 receptor like polypeptides and uses thereof
#1305IL-17 receptor like polypeptides and uses thereof
#1306IL-receptor like molecules and uses thereof
#1307Glycoproteins which bind to TNF
#1308Enzymatic activities in chemokine-mediated inflammation
#1309Diagnostics and therapeutics for diseases associated with chemokine receptor 11 (ccr11)
#1310Methods for determining the response of cells to vegf and uses thereof
#1311Immune response assessment method
#1312Human chemokine β-9 viral vectors
#1313Methods and compositions for modulating HGF/Met
#1314Anti-human VEGF receptor Flt-1 monoclonal antibody
#1315Methods and compositions for using MHC class II invariant chain polypeptide as a receptor for macrophage migration inhibitory factor
#1316Interleukin-8 homologous polypeptides and therapeutic uses thereof
#1317Human G-protein chemokine receptor HSATU68
#1318Techniques to treat neurological disorders by enhancing the presence of anti-inflammatory mediators
#1319Screening method for identifying compounds that selectively induce interferon alpha
#1320Multimarker panel based on PIGF for diabetes types 1 and 2
#1321Therapeutic and diagnostic proteins comprising a SOCS box
#1322CARD-4 molecules and uses thereof
#1323Method of identifying transmembrane protein-interacting compounds
#1324Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#1325Nucleic acids encoding human monoclonal antibodies to CTLA-4
#1326Methods of treatment with TR10 polypeptides
#1327Method and compositions for treating asthma
#1328Method for improved breast milk feeding to reduce the risk of allergy
#1329Simultaneous assay of target and target-drug binding
#1330Anti-human lymphotoxin alpha antibodies, compositions, methods and uses
#1331Methods of modulating immune responses by modulating tim-1, tim-2 and tim-4 function
#1332Methods for diagnosing labor
#1333Ephrin-B receptor protein involved in carcinoma
#1334Receptor for Oncostatin M
#1335Ztnf12, a tumor necrosis factor
#1336Method of screening cell growth inhibitor and cell growth inhibitor
#1337Biomarkers for age-related macular degeneration (AMD)
#1338Identification, monitoring and treatment of disease and characterization of biological condition using gene expression profiles
#1339Method of measuring activation of effector cells
#1340Antibodies to human chemokine beta-9
#1341Method for identifying a modulator of the binding of CCX CKR polypeptide to a chemokine
#1342IL-17 receptor like molecules and uses thereof
#1343Method of judging viral infection
#1344Decoy for treating and/or preventing th2 cytokine-associated allergic disease, gata3 mutant protein and medicinal compositions containing the same
#1345Functional inactivation of cxcr4-mediated responses in growth hormone transgenic mice through socs53 upregulation
#1346Methods of delivery of exogenous proteins to the cytosol and uses thereof
#1347Cytokines and cytokine receptors with reduced immunogenicity
#1348Compositions and methods for analysis of target analytes
#1349Chemokine-binding protein and methods of use
#1350Therapeutic and diagnostic agents
#1351Three-dimensional ex vivo angiogenesis system
#1352Methods for producing Ex vivo models for inflammatory disease and uses thereof
#1353Cell migration assay
#1354Extracellular TNF inhibitors for treating CNS disorders
#1355Eotaxin : eosinophil chemotactic cytokine
#1356Methods of establishing profiles for use in evaluating wound healing and biocompatibility of implant materials and microarrays useful therefor
#1357Composition and methods afor diagnosis and treatment of cardiovascular disorders
#1358Method for the rapid diagnosis of infectious disease by detection and quantitation of microorganism induced cytokines
#1359Hsp peptides and analogs for modulation of immune responses via antigen presenting cells
#1360Treating arthritis by cleaving TNF receptors
#1361Tumour markers and biological applications thereof
#1362Systems and methods for characterizing kidney diseases
#1363Viral protein binding compositions and methods
#1364Treatment of pancreatitis using alpha 7 receptor-binding cholinergic agonists
#1365Method for diagnosing increased risk of preeclampsia
#1366Equine P-selectin glycoprotein ligand-1 and uses thereof
#1367Method for determining embryo quality
#1368Treatment of rheumatoid arthritis with CD99 antagonists
#1369Systems and methods for characterizing kidney diseases
#1370Interferon gamma in the detection and treatment of angiomyolipomas
#1371Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators
#1372Diagnostics and remedies for interstitial pneumonia
#1373Pharmaceutical compositions for treating arthritis and inflammatory disease
#1374Inhibition of tristetraproline for protection of the heart from cardiac injuries
#1375Assay method to monitor the response of anti-cytokine therapy
#1376Compositions of beta-defensin inducing agents
#1377Compositions and methods for detecting and treating diseases and conditions related to chemokine receptors
#1378Enhancing the circulating half-life of interleukin-2 proteins
#1379Systems and methods for characterizing a biological condition or agent using precision gene expression profiles
#1380Agonists and antagonists of moxifin for the treatment of metabolic disorders
#1381Biomarkers for differentiating between type 1 and type 2 diabetes
#1382Methods and compositions relating to HPV-associated pre-cancerous and cancerous growths, including CIN
#1383Novel polynucleotides and uses therefor
#1384Methods for identifying active compounds
#1385Diagnostic indicator of thymic function
#1386Methods and compositions for modulating HGF/Met
#1387Methods and compositions for the diagnosis of asthma
#1388Nucleic acid encoding eosinophil eotaxin receptor
#1389WSX receptor agonist antibodies
#1390Cytokine receptor
#1391Novel molecules of the herpesvirus-entry-mediator-related protein family and uses thereof
#1392IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides
#1393IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAs and polypeptides
#1394IL-1 zeta, IL-1 zeta splice variants and Xrec2 DNAS and polypeptides
#1395Polynucleotide encoding IL-1 zeta, TDZ.1 isoform polypeptide
#1396Xobesin agonists and antagonists for the treatment of metabolic disorders
#1397N-TRADD active site and uses thereof
#1398Methods for determining clinical response to TNF-alpha and/or JAK inhibitors in subjects with inflammatory diseases
#1399Peptides for use in treatment and diagnosis of type 1 diabetes
#1400Quantification of misfolded TNFR2:Fc
#1401Molecular diagnostic kits for evaluating stress